baccaratblue| Everbright Securities: Focus on the application of synthetic biology technology

News summary

[Everbright Securities: Focus on the application of synthetic biology technology] Securities Times NewsbaccaratblueEverbright Securities Research News pointed out that it is recommended to pay attention to the application of synthetic biology technology. Recently, the concept of synthetic biology has become popular. Synthetic biology has adopted engineering design concepts to transform or create people who transcend natural functionsbaccaratblue...

Newsletter text

[Everbright Securities: Focus on the application of synthetic biology technology] Securities Times News, Everbright Securities Research News pointed out that it is recommended to pay attention to the application of synthetic biology technology. Recently, the concept of synthetic biology has become popular. Synthetic biology has adopted engineering design concepts to transform or create artificial living systems or functional systems that transcend natural functions. In a broad sense, it can be defined as replacing fossil-based materials with bio-based materials and using biotechnology The technology route replaces the traditional chemical technology route. Its application in the field of biomedicine is mainly in the two directions of innovative drugs and innovative therapies, raw materials and pharmaceutical intermediates. Individual stocks can be paid attention to: Boteng Shares, Chuanning Biotech, Hanyu Pharmaceutical, etc. Proofread: Su Huanwen